​

Lipocine (LPCN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

LPCN Stock Forecast

Lipocine (LPCN) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $15.00, with a high of $15.00 and a low of $15.00. This represents a 66.85% increase from the last price of $8.99.

- $3 $6 $9 $12 $15 High: $15 Avg: $15 Low: $15 Last Closed Price: $8.99

LPCN Stock Rating

Lipocine stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

LPCN Price Target Upside V Benchmarks

TypeNameUpside
StockLipocine66.85%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$15.00$15.00
Last Closing Price$8.99$8.99$8.99
Upside/Downside-66.85%66.85%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26-2---2
Feb, 26-2---2
Jan, 26-2---2
Dec, 25-2---2
Nov, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 21, 2026H.C. Wainwright$15.00$9.9251.21%66.85%
Sep 24, 2024Scott HenryIndustrial Alliance Securities$10.00$4.54120.26%11.23%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 21, 2026H.C. WainwrightBuyBuyhold
Sep 24, 2024Alliance Global PartnersBuyinitialise

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.19$-2.15$-3.14-$-1.77---
Avg Forecast$-2.49$-2.15$-2.99$-0.76$-1.22$-1.15$-0.55$0.10
High Forecast$-1.80$-1.52$-1.25$-0.31$-0.51$-0.48$-0.23$0.16
Low Forecast$-3.18$-2.78$-4.73$-1.20$-1.93$-1.82$-0.87$0.04
Surprise %-92.37%-5.02%-45.08%---

Revenue Forecast

$-5M $2M $9M $16M $23M $30M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.14M$500.00K$-2.85M$11.20M$1.98M---
Avg Forecast$3.75M$1.81M$-3.07M$9.06M$3.45M$2.61M$8.20M$18.73M
High Forecast$4.55M$2.21M$-1.69M$10.32M$5.00M$2.61M$8.20M$27.13M
Low Forecast$2.95M$1.40M$-4.44M$7.79M$1.90M$2.61M$8.20M$10.32M
Surprise %330.23%-72.31%-7.05%23.66%-42.66%---

Net Income Forecast

$-25M $-19M $-13M $-7M $-1M $5M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-634.40K$-10.76M$-16.35M$8.35K$-9.63M---
Avg Forecast$-13.14M$-11.35M$-16.35M$-4.06M$-6.43M$-6.06M$-2.90M$526.97K
High Forecast$-9.50M$-8.03M$-6.56M$-1.66M$-2.68M$-2.52M$-1.21M$834.45K
Low Forecast$-16.77M$-14.67M$-24.95M$-6.30M$-10.18M$-9.60M$-4.59M$219.46K
Surprise %-95.17%-5.19%-0.00%-100.21%49.75%---

LPCN Forecast FAQ

Is Lipocine stock a buy?

Lipocine stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lipocine is a favorable investment for most analysts.

What is Lipocine's price target?

Lipocine's price target, set by 9 Wall Street analysts, averages $15 over the next 12 months. The price target range spans from $15 at the low end to $15 at the high end, suggesting a potential 66.85% change from the previous closing price of $8.99.

How does Lipocine stock forecast compare to its benchmarks?

Lipocine's stock forecast shows a 66.85% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Lipocine over the past three months?

  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Lipocine’s EPS forecast?

Lipocine's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.15, marking a -35.03% decrease from the reported $-1.77 in 2025. Estimates for the following years are $-0.55 in 2027, and $0.1 in 2028.

What is Lipocine’s revenue forecast?

Lipocine's average annual revenue forecast for its fiscal year ending in December 2026 is $2.61M, reflecting a 32.01% increase from the reported $1.98M in 2025. The forecast for 2027 is $8.2M, and $18.73M for 2028.

What is Lipocine’s net income forecast?

Lipocine's net income forecast for the fiscal year ending in December 2026 stands at $-6.06M, representing a -37.05% decrease from the reported $-9.628M in 2025. Projections indicate $-2.898M in 2027, and $526.97K in 2028.